1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemEPranoprofenCat. No.: HY-B0336CAS No.: 52549-17-4分式: CHNO分量: 255.27作靶點: PGE synthase作通路: Immunology/Inflammation儲存式: Powder -20C 3 years4C 2 yearsIn solvent -80C 6 months-20C 1 month溶解性數據體外實驗 DMSO : 100 mg/mL (391.74 mM)* means s

2、oluble, but saturation unknown.Mass Solvent1 mg 5 mg 10 mg Concentration制備儲備液1 mM 3.9174 mL 19.5871 mL 39.1742 mL5 mM 0.7835 mL 3.9174 mL 7.8348 mL10 mM 0.3917 mL 1.9587 mL 3.9174 mL請根據產品在不同溶劑中的溶解度，選擇合適的溶劑配制儲備液，并請注意儲備液的保存式和期限。體內實驗請根據您的實驗動物和給藥式選擇適當的溶解案，配制前請先配制澄清的儲備液，再依次添加助溶劑(為保證實驗結果的可靠性，體內實驗的作液，建議您現現

3、配，當天使；澄清的儲備液可以根據儲存條件，適當保存；以下溶劑前的百分 指該溶劑在您配制終溶液中的體積占)：1. 請依序添加每種溶劑： 10% DMSO 40% PEG300 5% Tween-80 45% salineSolubility: 2.5 mg/mL (9.79 mM); Clear solution2. 請依序添加每種溶劑： 10% DMSO 90% (20% SBE-CD in saline)Solubility: 2.5 mg/mL (9.79 mM); Clear solution3. 請依序添加每種溶劑： 10% DMSO 90% corn oil1/2 Master of

4、 Small Molecules 您邊的抑制劑師www.MedChemESolubility: 2.5 mg/mL (9.79 mM); Clear solutionBIOLOGICAL ACTIVITY物活性 Pranoprofen甾體抗炎化合物，可作于眼科疾病。REFERENCES1. Akyol-Salman, I., D. Lece-Sertoz, and O. Baykal, Topical pranoprofen 0.1% is as effective anti-inflammatory and analgesic agent asdiclofenac sodium 0.1% a

5、fter strabismus surgery. J Ocul Pharmacol Ther, 2007. 23(3): p. 280-3.2. Notivol, R., M. Martinez, and M.V. Bergamini, Treatment of chronic nonbacterial conjunctivitis with a cyclo-oxygenase inhibitor or acorticosteroid. Pranoprofen Study Group. Am J Ophthalmol, 1994. 117(5): p. 651-6.3. Hosoi, T., et al., Effect of pranoprofen on endoplasmic reticulum stress in the primary cultured glial cells. Neurochem Int, 2009. 54(1): p.1-6.McePdfHeightCaution: Product has not been fully validated for medical applications.For research use only.Tel: 400-820-37